Gilead sciences statement on expanding global supply of investigational antiviral remdesivir

Since January, Gilead has worked with speed, care, and diligence to prepare for the possibility that the company’s investigational antiviral remdesivir may be found effective against the virus that causes COVID-19. Recent clinical trial…